CATALIOTTI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 229
AS - Asia 79
EU - Europa 59
AF - Africa 19
SA - Sud America 10
OC - Oceania 1
Totale 397
Nazione #
US - Stati Uniti d'America 223
SG - Singapore 46
CN - Cina 25
IE - Irlanda 17
CI - Costa d'Avorio 14
IT - Italia 11
UA - Ucraina 11
BR - Brasile 10
SE - Svezia 7
CA - Canada 6
DE - Germania 6
RU - Federazione Russa 5
SN - Senegal 5
IN - India 3
UZ - Uzbekistan 2
VN - Vietnam 2
AT - Austria 1
AU - Australia 1
GB - Regno Unito 1
SA - Arabia Saudita 1
Totale 397
Città #
Santa Clara 34
Chandler 31
Singapore 28
Dallas 26
Jacksonville 21
Dublin 17
Chicago 16
Ashburn 15
Abidjan 14
Boardman 8
Beijing 7
Council Bluffs 6
Nanjing 6
Andover 5
Cambridge 5
Civitanova Marche 5
Dakar 5
Des Moines 5
Lawrence 5
Los Angeles 5
Toronto 5
Grafing 4
Catania 2
Charlotte 2
Curitiba 2
Hangzhou 2
Ho Chi Minh City 2
Jiaxing 2
Pune 2
Seattle 2
Shenyang 2
Apiaí 1
Atlanta 1
Bremen 1
Brooklyn 1
Buffalo 1
Campinas 1
Chennai 1
Concord 1
Dammam 1
Erechim 1
Hebei 1
Kansas City 1
Minaçu 1
Moscow 1
Nanchang 1
Nazaré da Mata 1
Ottawa 1
Redondo Beach 1
Ribeirão Claro 1
Saint Petersburg 1
San Mateo 1
Stockholm 1
Sydney 1
Taizhou 1
Taubaté 1
Tubarão 1
Washington 1
Totale 318
Nome #
PLASMA CONCENTRATION OF ASYMMETRICAL DYMETHYLARGININE AND MORTALITY IN PATIENTS WITH END STAGE RENAL DISEASE: “A PROSPECTIVE STUDY” . 91
Soluble E-selectina is an marker of outcome in end renal disease and interacts with inflammation to determine cardiovascular risk 90
Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease 84
Norepinephrine and concentric hypertrophy in patients with end-stage renal disease 78
HYPEROMOCISTEINEMIA PREDICTS CARDIOVASCULAR OUTCOMES IN HEMODIALYSIS PATIENTS 59
Totale 402
Categoria #
all - tutte 1.560
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.560


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202125 0 0 0 0 6 1 5 0 5 0 6 2
2021/202234 5 5 0 1 6 0 5 0 2 0 0 10
2022/202376 5 0 1 5 15 16 0 15 17 1 1 0
2023/202446 2 13 2 1 0 9 8 2 0 3 6 0
2024/2025106 5 23 4 5 26 15 2 0 5 11 5 5
2025/202672 13 10 22 10 17 0 0 0 0 0 0 0
Totale 402